NCT00828646 Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese Status COMPLETED Phase PHASE1
NCT00827411 Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy Status COMPLETED Phase PHASE4
NCT00826449 Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT00825955 Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment Status COMPLETED Phase PHASE3
NCT00825929 Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. Status RECRUITING Phase N/A
NCT00825734 Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00823550 Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients Status UNKNOWN Phase PHASE4
NCT00821886 Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT00820170 Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 Status COMPLETED Phase PHASE1/PHASE2
NCT00816959 Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma Status UNKNOWN Phase PHASE3
NCT00814268 COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke Status COMPLETED Phase PHASE4
NCT00810147 A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00804310 Lapatinib and Ixabepilone in Treating Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT00803647 A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Status COMPLETED Phase PHASE2
NCT00803556 Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy Status COMPLETED Phase PHASE1
NCT00803374 Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma Status WITHDRAWN Phase PHASE1
NCT00799045 Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects Status COMPLETED Phase PHASE4
NCT00798252 Ascending Multiple-Dose Study of Brivanib Alaninate in Combination With Chemotherapeutic Agents in Subjects With Advanced Cancers Status COMPLETED Phase PHASE1